Arix leads $45M series B for gene therapy biotech LogicBio – FierceBiotech
FierceBiotech |
Arix leads $45M series B for gene therapy biotech LogicBio
FierceBiotech LogicBio Therapeutics has got off a $45 million series B funding round as it eyes the cash for disease-modifying gene therapies in rare childhood diseases. London-based investment firm Arix Bioscience led the oversubscribed round in the semi-stealth … Gene therapy co LogicBio raises $50m Arix Bioscience leads $45 million Series B financing round into LogicBio Therapeutics Arix Bioscience has led a $45m funding round in US gene therapy company |
